News for Aurobindo Pharma Limited (AUROPHARMA.BO)

The Nifty Pharma index closed 1.4 per cent up at 21738.95.

The Nifty Pharma index closed 0.41 per cent up at 21438.05.

The Nifty Pharma index was trading 0.5 per cent up at 21458.35.

The Nifty Pharma index closed 1.06 per cent up at 21351.05.

Indian benchmark equity indices closed higher on Thursday to log their best week in more than four years and erase all their year-to-date losses, led by a rally in heavyweight financial stocks.

The Nifty Pharma index closed 1.21 per cent up at 21126.75.

The Nifty Pharma index closed 2.2 per cent up at 20912.2.

Stocks including TCS, Tata Steel, GAIL (India), Infosys, BHEL, Sun Pharma, NBCC (India), Bharti Hexacom, Eternal, Aurobindo Pharma and TARC will be in the spotlight on Friday, April 10.

Aurobindo Pharma and Gland Pharma have fallen 9 per cent each in the past one week and 22-23 per cent in 2025 so far. Glenmark Pharma is down 9 per cent for the one month period and 14 per cent year-to-date.

The Nifty Pharma index closed 1.97 per cent down at 19976.3.

RBI Governor Sanjay Malhotra acknowledged that US tariff measures have increased uncertainties, making it difficult to assess the impact on economic growth. While growth is improving, it remains below desired levels. The MPC has revised the FY26 GDP growth forecast downward by 20 basis points to 6.5%, citing headwinds from global trade and inflation.

The Nifty Pharma index was trading 1.78 per cent down at 20015.95.

Global stock markets plunged after President Trump announced a 10% blanket tariff on all U.S. trading partners, with higher rates for surplus countries like India at 26%. This triggered fears of a trade war and recession, impacting the Indian Sensex and Nifty50, and hitting sectors like metals, pharma, and IT hard.

Sensex tanks 800 pts, Nifty 50 trades below 23,000 level. Bajaj Finance & HDFC Bank lead gainers. ONGC, Hindalco, Tata Motors and Cipla drag

Stock Market Crash Today: Indian stock markets experienced a sharp drop as renewed recession fears and President Trump's new tariff announcements sparked a global selloff. The Sensex fell 836 points, with broad-based selling pulling down sectoral indices including metal, pharma, and IT. Investor sentiment was affected by potential tariffs targeting the pharma sector and heightened global uncertainty.

The exemption given to Indian pharmaceuticals is positive and, therefore, this segment is likely to witness buying, says analyst.

The NSE Nifty index was trading 43.5 points down at 23288.85

The Nifty Pharma index closed 0.87 per cent up at 20952.85.

The Nifty Pharma index was trading 0.4 per cent up at 20854.8.